Granulomatous amoebic encephalitis primary prevention: Difference between revisions
No edit summary |
m Changes made per Mahshid's request |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Granulomatous amoebic encephalitis}} | {{Granulomatous amoebic encephalitis}} | ||
Line 14: | Line 13: | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{wikiDoc Sources}} | {{wikiDoc Sources}} |
Latest revision as of 17:50, 18 September 2017
Granulomatous amoebic encephalitis Microchapters |
Differentiating Granulomatous amoebic encephalitis from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Granulomatous amoebic encephalitis primary prevention On the Web |
American Roentgen Ray Society Images of Granulomatous amoebic encephalitis primary prevention |
FDA on Granulomatous amoebic encephalitis primary prevention |
CDC on Granulomatous amoebic encephalitis primary prevention |
Granulomatous amoebic encephalitis primary prevention in the news |
Blogs on Granulomatous amoebic encephalitis primary prevention |
Directions to Hospitals Treating Granulomatous amoebic encephalitis |
Risk calculators and risk factors for Granulomatous amoebic encephalitis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Currently, there are no known ways to prevent infection with Balamuthia since it is unclear how and why some people become infected while others do not. There have been no reports of a Balamuthia infection spreading from one person to another except through organ donation/transplantation.
References